Markets Gone Wild

Breaking News: OS Therapies Announces Agreements for Commercial Manufacture of OST-HER2 New York–(BUSINESS WIRE)–OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the commercial manufacture of OST-HER2. Exciting Developments in Cancer Treatment OS Therapies, Inc. is making…

Exchange Listed Funds Trust Announces Plan for Liquidation On March 28, 2025, Exchange Traded Concepts, LLC, the investment adviser for Exchange Listed Funds Trust (the “Fund”), made a recommendation to the Fund’s Board of Trustees for the termination and liquidation of the Fund. After thorough deliberation, the Board of Trustees approved the recommendation, and the…

Curious Human: I’ve recently experienced a significant loss on my Neumora Therapeutics, Inc. (NMRA) investment. What actions can I take under federal securities laws to potentially recover my losses? My dear inquisitive friend, I’m glad you’ve asked such an important question. Let me first assure you that I’m here to help in any way I…

Cleveland-Cliffs: A Rollercoaster Ride in the Steel Industry Cleveland-Cliffs Inc. (CLF), a leading global producer of iron ore pellets, has experienced a tumultuous ride in the stock market recently. After receiving a “Buy” rating from me back in 2023, the stock has dropped a staggering 26%. This decline might give investors pause, but I’d like…